Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

104 results about "Staphylococcus Phages" patented technology

Viruses whose host is Staphylococcus.

Phage lyase mutant-based MRSA and drug-resistant gene nucleic acid POCT rapid detection kit, rapid extraction and purification reagent and triple PCR rapid amplification detection reagent

The invention provides a kit for rapidly detecting MRSA and drug-resistant gene nucleic acid POCT of the MRSA based on a phage lyase mutant. The kit comprises nucleic acid extraction and purification and triple PCR rapid amplification detection reagents. The staphylococcus aureus bacteriophage lyase mutant nucleic acid release liquid containing the amino acid sequence as shown in SEQ ID NO: 1 is adopted, wall breaking can be rapidly conducted on staphylococcus aureus, and nucleic acid is released. The effect of the nucleic acid release liquid acting for 5 minutes is equivalent to or even better than that of the lysozyme acting for 60 minutes; according to the present invention, with the combination of the MRSA and drug-resistant gene triple PCR rapid amplification detection reagent, the total detection time is only 35 min, the time is saved by 55 min or more than 55 min compared with the lysozyme method, and the MRSA and drug-resistant gene nucleic acid POCT rapid detection can be achieved;
Owner:SHENZHEN TRADITIONAL CHINESE MEDICINE HOSPITAL

Cosmetic composition comprising an endolysine and a compound of formula (I)

Cosmetic composition comprising an endolysin and a compound of formula (I) The present invention relates to a composition, particularly a cosmetic one, comprising, in a physiologically acceptable medium, at least one endolysin, in particular an endolysin derived from a Staphylococcus aureus phage, and at least one compound of formula (I). It also relates to the use of such a composition to prevent and / or treat a skin disorder related to colonization by Staphylococcus aureus in an individual in need, in particular to prevent and / or treat acne and / or eczema in the individual, and a non-therapeutic cosmetic method for the care of keratinous materials, in particular skin, comprising at least one step of topical application of such a composition to said keratinous materials. Figure for abstract: None
Owner:LOREAL SA

Staphylococcus aureus bacteriophage Lm44 perforin as well as preparation method and application thereof

The invention discloses staphylococcus aureus bacteriophage Lm44 perforin as well as a preparation method and application thereof, and relates to the technical field of bioengineering, the amino acid sequence of the perforin is shown as SEQ ID NO: 1, and the nucleotide sequence for coding the perforin is shown as SEQ ID NO: 2. The staphylococcus aureus bacteriophage Lm44 perforin is applied to preparation of a medicine for treating cow mastitis. Whole genome information of the bacteriophage Lm44 is obtained, the perforin HolLm44 of the bacteriophage Lm44 is successfully cloned, expressed and purified, and the perforin has a good antibacterial effect and can provide a theoretical basis for prevention and control of cow mastitis.
Owner:SHENYANG AGRI UNIV

Aqueous cosmetic composition comprising endolysine and trehalose

A cosmetic composition comprising an endolysin and trehalose. The present invention relates to a composition, particularly a cosmetic one, comprising, in a physiologically acceptable medium, at least one endolysin, in particular an endolysin derived from a Staphylococcus aureus phage, and trehalose. It also relates to the use of such a composition to prevent and / or treat a skin disorder related to Staphylococcus aureus colonization in an individual in need, and in particular to prevent and / or treat acne and / or eczema in an individual in need, and a non-therapeutic cosmetic method for the care of keratinous materials, in particular skin, comprising at least one step of topical application of such a composition to said keratinous materials. Figure for abstract: None
Owner:LOREAL SA

Enzymatically active domains from Anti-staphylococcal phage proteins

PCT designated stage expiredWO2024238670A2Antibacterial agentsAntibody mimetics/scaffoldsStaphylococcal PhagesStaphylococcus sp
The present disclosure relates to novel enzymatically active domains from Staphylococcus phage proteins. The disclosure also relates to cell wall hydrolases comprising these enzymatically active domains and uses thereof in the treatment of infection with Staphylococcus sp.
Owner:TOPAZ BIOSCIENCES INC

A broad-spectrum Staphylococcus aureus phage SapYZUbeta and its applications

This invention discloses a broad-spectrum Staphylococcus aureus bacteriophage, SapYZUbeta, and its applications. This bacteriophage has been deposited at the China Center for Type Culture Collection (CCTCC) on May 16, 2022, with accession number CCTCC NO: M 2022629. Identification revealed that the full-length gene of this bacteriophage is 17,790 bp, and it does not contain tRNAs or genes associated with lysogenicity, virulence, or antibiotic resistance. This genetic background confirms the safety of this bacteriophage for use against foodborne pathogens and for bacteriophage therapy. Furthermore, the bacteriophage exhibits a high titer of 1.9 × 10⁻⁶. 9 The phage, with a concentration of PFU / mL, exhibits stable activity within a pH range of 3–12 and a temperature range of -80–60°C, and can be applied to various matrices. The phage provided by this invention can lyse multidrug-resistant wild-type strains isolated from different regions, including MRSA and MSSA, and is characterized by a broad lysis spectrum and high lysis efficiency.
Owner:YANGZHOU UNIV

Cosmetic composition comprising an endolysin derived from a Staphylococcus aureus phage and a mineral filler

Cosmetic composition comprising an endolysin derived from a Staphylococcus aureus phage and a mineral filler. The present invention relates to a composition, particularly a cosmetic one, comprising, in a physiologically acceptable medium, at least one endolysin derived from a Staphylococcus aureus phage and at least one mineral filler selected from hydrophilic fumed silicas and spherical porous silica particles. It also relates to the use of such a composition to prevent and / or treat a skin disorder related to colonization by Staphylococcus aureus in an individual in need, and in particular to prevent and / or treat acne and / or eczema in an individual in need, and a non-therapeutic cosmetic process for the care of keratinous materials, particularly skin, comprising at least one step of topical application of such a composition to said keratinous materials.
Owner:LOREAL SA

Cosmetic composition comprising endolysin derived from staphylococcus aureus bacteriophage and oil

The present invention relates to a composition, in particular a cosmetic composition, comprising, in a physiologically acceptable medium, at least one endolysin derived from Staphylococcus aureus bacteriophage and at least one oil other than liquid paraffin. The invention also relates to the use of such a composition for the prevention and / or treatment of skin conditions associated with colonization of Staphylococcus aureus in a subject in need thereof, and in particular for the prevention and / or treatment of acne and / or eczema in a subject, and to a non-therapeutic cosmetic method for caring for keratin materials, in particular skin, it comprises at least one step of topically applying such a composition to the keratin material.
Owner:LOREAL SA

Culture medium for staphylococcus aureus phage fermentation and fermentation method

The invention relates to the technical field of microorganisms, in particular to a culture medium for staphylococcus aureus phage fermentation and a fermentation method. According to the culture medium for staphylococcus aureus bacteriophage fermentation, the problems that in large-scale culture of staphylococcus aureus bacteriophages, excessive accumulation of host bacteria biofilm precursor substances is caused by a high-nutrition environment is achieved through cooperation of whey protein hydrolysate, humic acid, chitosan and the like are solved, and the yield of the staphylococcus aureus bacteriophages is increased; the method solves the problems of bacteriophage infection efficiency reduction and amplification resistance, improves the bacteriophage titer, and shortens the fermentation period.
Owner:WUHAN GRENON BIOTECHNOLOGY CO LTD

Cosmetic composition comprising an endolysin derived from Staphylococcus aureus phage and an aromatic alcohol

Cosmetic composition comprising an endolysin derived from a Staphylococcus aureus phage and an aromatic alcohol. The present invention relates to a composition, particularly a cosmetic one, comprising, in a physiologically acceptable medium, at least one endolysin derived from a Staphylococcus aureus phage and at least one aromatic alcohol of formula (I). It also relates to the use of such a composition to prevent and / or treat a skin disorder related to colonization by Staphylococcus aureus in an individual in need, and in particular to prevent and / or treat acne and / or eczema in an individual in need, and a non-therapeutic cosmetic method for the care of keratinous materials, particularly skin, comprising at least one step of topical application of such a composition to said keratinous materials. Figure for abstract: None
Owner:LOREAL SA

CRISPR-Cas9 system-based phage genome editing vector as well as editing method and application thereof

The invention discloses a bacteriophage genome editing vector based on a CRISPR-Cas9 system as well as an editing method and application of the bacteriophage genome editing vector. According to the invention, a plasmid containing a cas9 gene and an sgRNA element is successfully constructed, a specific primer is designed for an editing site, and a pTarget plasmid is obtained; a donor DNA sequence is constructed on a vector, and a pEdit plasmid is obtained. After the bacteriophage is infected with host bacteria containing pEdit plasmids, the mutant bacteriophage is reversely screened through pTarget plasmids, and efficient and rapid gene editing, including gene deletion mutation, mononucleotide replacement mutation and insertion mutation, of the bacteriophage genome is achieved. The method is simple to operate and high in gene editing efficiency, promotes the structural analysis and functional research development of the staphylococcus aureus bacteriophage genome, provides a new strategy for the transformation of engineering bacteriophages, and has wide application prospects and market values.
Owner:YANGZHOU UNIV

Anhydrous composition comprising an endolysine and hydroxypropylmethylcellulose and / or pullulan

An anhydrous composition comprising an endolysin and hydroxypropylmethylcellulose and / or pullulan. The present invention relates to an anhydrous composition, particularly a cosmetic one, comprising (i) at least one endolysin, in particular an endolysin derived from a Staphylococcus aureus phage; and (ii) hydroxypropylmethylcellulose and / or pullulan. It also relates to a composition comprising, in a physiologically acceptable medium, at least one anhydrous composition of the invention. It further relates to the use of such a composition to prevent and / or treat a skin disorder related to Staphylococcus aureus colonization in an individual in need, as well as a non-therapeutic cosmetic method for the care of keratinous materials comprising at least one step of topical application of the composition to said keratinous materials.The invention also relates to a non-therapeutic cosmetic method for the care of keratinous materials, comprising the topical application of a composition according to the invention and a method for stabilizing an endolysin, in particular an endolysin derived from a Staphylococcus aureus phage. Figure for the abstract: None.
Owner:LOREAL SA

Staphylococcus aureus bacteriophage SapLY01 and application thereof

PendingCN119060963AEfficient killingshort incubation periodBiocideAntibacterial agentsStaphylococcal PhagesMicrobiology
The invention discloses a staphylococcus aureus phage SapLY01, the staphylococcus aureus phage SapLY01 is Staphylococcus aureus phage SapLY01, and the preservation number of the staphylococcus aureus phage SapLY01 is CCTCC (China Center For Type Culture Collection) CNO: M 2024014. The staphylococcus aureus bacteriophage SapLY01 is short in latency period, wide in splitting spectrum, high in splitting capacity, capable of rapidly killing host bacteria, small in toxic and side effect, high in safety, wide in temperature and acid-base tolerance range, good in hydrophilicity, easy to prepare into spraying agents and injection, capable of effectively killing clinically separated staphylococcus aureus and good in application prospect. The pollution of the staphylococcus aureus to the environment can be effectively inhibited, and a very good treatment effect on animals infected with the staphylococcus aureus is achieved.
Owner:GUANGXI UNIV

Cosmetic composition comprising an endolysin and hydrophobic silica aerogel particles

Cosmetic composition comprising an endolysin and hydrophobic silica aerogel particles. The present invention relates to a composition, particularly a cosmetic one, comprising, in a physiologically acceptable medium, at least one endolysin, in particular an endolysin derived from a Staphylococcus aureus phage, and at least some hydrophobic silica aerogel particles. It also relates to the use of such a composition to prevent and / or treat a skin disorder related to colonization by Staphylococcus aureus in an individual in need, and in particular to prevent and / or treat acne and / or eczema in an individual in need, and a non-therapeutic cosmetic method for the care of keratinous materials, in particular skin, comprising at least one step of topical application of such a composition to said keratinous materials.
Owner:LOREAL SA

Cosmetic composition comprising an endolysin derived from Staphylococcus aureus phage and an aromatic alcohol

Cosmetic composition comprising an endolysin derived from a Staphylococcus aureus phage and an aromatic alcohol. The present invention relates to a composition, particularly a cosmetic one, comprising, in a physiologically acceptable medium, at least one endolysin derived from a Staphylococcus aureus phage and at least one aromatic alcohol of formula (I). It also relates to the use of such a composition to prevent and / or treat a skin disorder related to colonization by Staphylococcus aureus in an individual in need, and in particular to prevent and / or treat acne and / or eczema in an individual in need, and a non-therapeutic cosmetic method for the care of keratinous materials, particularly skin, comprising at least one step of topical application of such a composition to said keratinous materials. Figure for abstract: None
Owner:LOREAL SA

Cosmetic composition comprising an endolysin and an organic filler

The present invention relates to a composition, notably a cosmetic composition, comprising, in a physiologically acceptable medium, at least one endolysin, in particular an endolysin derived from a Staphylococcus aureus phage, and at least one organic filler chosen from an unmodified starch, an N-acylamino acid, salts thereof and mixtures thereof. The invention also relates to the use of such a composition for preventing and / or treating a skin disorder linked to colonization by Staphylococcus aureus in an individual in need thereof, and in particular for preventing and / or treating acne and / or eczema in an individual in need thereof, and to a non-therapeutic cosmetic process for caring for keratin materials, in particular the skin, comprising at least one step of topical application to said keratin materials of such a composition.
Owner:LOREAL SA

Anhydrous cosmetic composition comprising an endolysin derived from Staphylococcus aureus phage and mannitol.

An anhydrous composition comprising an endolysin derived from a Staphylococcus aureus phage and mannitol. The present invention relates to an anhydrous composition comprising (i) at least one endolysin derived from a Staphylococcus aureus phage; and (ii) mannitol, the endolysin comprising a protein sequence having at least 80% sequence identity with an amino acid sequence selected from the group consisting of the reference amino acid sequences SEQ ID NO: 1 and SEQ ID NO: 2. It also relates to a composition comprising, in a physiologically acceptable medium, at least one anhydrous composition of the invention.It also covers the use of such a composition to prevent and / or treat a skin disorder related to Staphylococcus aureus colonization in an individual in need, and a non-therapeutic cosmetic process for the care of keratinous materials comprising at least one step of topical application of such a composition to said keratinous materials. Finally, it covers a process for stabilizing an endolysin derived from a Staphylococcus aureus phage. Figure for the abstract: None.
Owner:LOREAL SA

Cosmetic composition comprising an endolysin and a polyvinyl alcohol

The present invention relates to a composition, notably a cosmetic composition, comprising, in a physiologically acceptable medium, at least one endolysin, in particular an endolysin derived from a Staphylococcus aureus phage, and at least one polyvinyl alcohol. The invention also relates to the use of such a composition for preventing and / or treating acne and / or eczema in an individual in need thereof, and to a non-therapeutic cosmetic process for caring for keratin materials, in particular the skin, notably dry skin, comprising at least one step of topical application of such a composition to said keratin materials.
Owner:LOREAL SA

Aqueous cosmetic composition comprising endolysine and trehalose

A cosmetic composition comprising an endolysin and trehalose. The present invention relates to a composition, particularly a cosmetic one, comprising, in a physiologically acceptable medium, at least one endolysin, in particular an endolysin derived from a Staphylococcus aureus phage, and trehalose. It also relates to the use of such a composition to prevent and / or treat a skin disorder related to Staphylococcus aureus colonization in an individual in need, and in particular to prevent and / or treat acne and / or eczema in an individual in need, and a non-therapeutic cosmetic method for the care of keratinous materials, in particular skin, comprising at least one step of topical application of such a composition to said keratinous materials. Figure for abstract: None
Owner:LOREAL SA

Cosmetic composition comprising an endolysin derived from Staphylococcus aureus phage and 4-hydroxyacetophenone

L'Oréal Cosmetic Composition Comprising an Endolysin Derived from a Staphylococcus aureus Phage and 4-Hydroxyacetophenone. The present invention relates to a composition, particularly a cosmetic one, comprising, in a physiologically acceptable medium, at least one endolysin derived from a Staphylococcus aureus phage and 4-hydroxyacetophenone. It also relates to the use of such a composition to prevent and / or treat a skin disorder related to colonization by Staphylococcus aureus in an individual in need, and in particular to prevent and / or treat acne and / or eczema in an individual in need, and a non-therapeutic cosmetic method for the care of keratinous materials, particularly skin, comprising at least one step of topical application of such a composition to said keratinous materials. Figure for abstract: None
Owner:LOREAL SA

Cosmetic composition comprising endolysin derived from staphylococcus aureus bacteriophage and aromatic alcohol

The present invention relates to a composition, in particular a cosmetic composition, comprising, in a physiologically acceptable medium, at least one endolysin derived from a Staphylococcus aureus bacteriophage and at least one aromatic alcohol of formula (I). The invention also relates to the use of such a composition for the prevention and / or treatment of skin conditions associated with colonization of Staphylococcus aureus in a subject in need thereof, and in particular for the prevention and / or treatment of acne and / or eczema in a subject in need thereof, and to a non-therapeutic cosmetic process for caring for a keratin material, in particular skin, comprising at least one step of topically applying such a composition to said keratin material.
Owner:LOREAL SA

Staphylococcus aureus bacteriophage and application thereof

The invention provides a staphylococcus aureus phage and application of the staphylococcus aureus phage, the staphylococcus aureus phage is staphylococcus aureus phage GRNSAP30, and the preservation number of the staphylococcus aureus phage is CCTCC (China Center for Type Culture Collection) NO: M2024537. The phage GRNSAP30 disclosed by the invention has a cleaning effect on staphylococcus aureus of vegetable, fruit or meat packaging materials, and can be used for effectively reducing the bacterium loading amount of the staphylococcus aureus in food packaging materials and reducing the food poisoning rate caused by staphylococcus aureus pollution; the invention provides a safe biological scavenger without toxic and side effects for resisting food poisoning caused by grape balls.
Owner:WUHAN GRENON BIOTECHNOLOGY CO LTD

Cosmetic composition comprising an endolysin derived from a staphylococcus aureus phage and a polyhydroxyalkane

The present invention relates to a composition, notably a cosmetic composition, comprising, in a physiologically acceptable medium, at least one endolysin derived from a Staphylococcus aureus phage, and at least one polyhydroxyalkane of formula (I) The invention also relates to the use of such a composition for preventing and / or treating a skin disorder linked to colonization by Staphylococcus aureus in an individual in need thereof, and in particular for preventing and / or treating acne and / or eczema in an individual in need thereof and to a non-therapeutic cosmetic process for caring for keratin materials, in particular the skin, comprising at least one step of topical application to said keratin materials of such a composition.
Owner:LOREAL SA

Cosmetic composition, particularly aqueous, comprising an endolysin and a pullulan

A cosmetic composition, particularly aqueous, comprising an endolysin and a pullulan. The present invention relates to a composition, particularly a cosmetic one, comprising, in a physiologically acceptable medium, at least one endolysin, in particular an endolysin derived from a Staphylococcus aureus phage, and at least one pullulan. It also relates to the use of such a composition to prevent and / or treat a skin disorder related to Staphylococcus aureus colonization in an individual in need, and in particular to prevent and / or treat acne and / or eczema in an individual in need, and a non-therapeutic cosmetic method for the care of keratinous materials, particularly skin, comprising at least one step of topical application of such a composition to said keratinous materials. Figure for abstract: None
Owner:LOREAL SA

Phage genome editing vector based on CRISPR-Cas9 system and its editing method and application

The present invention discloses a phage genome editing vector based on the CRISPR-Cas9 system and its editing method and application. red9 A plasmid containing the gene and sgRNA elements is constructed, and specific primers are designed for the editing site to obtain the pTarget plasmid; the donor DNA sequence is constructed into a vector to obtain the pEdit plasmid. After phage is infected with a host bacteriophage containing the pEdit plasmid, the pTarget plasmid is used to reverse screen for mutant phage, achieving efficient and rapid gene editing of the phage genome, including gene deletion mutations, single nucleotide substitution mutations, and insertion mutations. This method is simple to operate and has high gene editing efficiency. It has promoted the development of structural analysis and functional research of Staphylococcus aureus phage genomes and provided a new strategy for the modification of engineered phages, with broad application prospects and market value.
Owner:YANGZHOU UNIV

Cosmetic composition comprising an endolysin derived from Staphylococcus aureus phage and a polyhydroxyalkane

L'Oréal Cosmetic Composition Comprising an Endolysin Derived from a Staphylococcus aureus Phage and a Polyhydroxyalkane. The present invention relates to a composition, particularly a cosmetic one, comprising, in a physiologically acceptable medium, at least one endolysin derived from a Staphylococcus aureus phage and at least one polyhydroxyalkane of formula (I). It also relates to the use of such a composition to prevent and / or treat a skin disorder related to colonization by Staphylococcus aureus in an individual in need, and in particular to prevent and / or treat acne and / or eczema in an individual in need, and a non-therapeutic cosmetic process for the care of keratinous materials, particularly of the skin, comprising at least one step of topical application of such a composition to said keratinous materials. Figure for abstract: None
Owner:LOREAL SA

Cosmetic composition comprising an endolysin derived from Staphylococcus aureus phage and an oil.

Cosmetic composition comprising an endolysin derived from a Staphylococcus aureus phage and an oil. The present invention relates to a composition, particularly a cosmetic one, comprising, in a physiologically acceptable medium, at least one endolysin derived from a Staphylococcus aureus phage and at least one oil distinct from a paraffin oil. It also relates to the use of such a composition to prevent and / or treat a skin disorder related to colonization by Staphylococcus aureus in an individual in need, in particular to prevent and / or treat acne and / or eczema in the individual, and a non-therapeutic cosmetic method for the care of keratinous materials, particularly of the skin, comprising at least one step of topical application of such a composition to said keratinous materials. Figure for abstract: None
Owner:LOREAL SA

Anhydrous cosmetic composition comprising an endolysin derived from Staphylococcus aureus phage and mannitol.

An anhydrous composition comprising an endolysin derived from a Staphylococcus aureus phage and mannitol. The present invention relates to an anhydrous composition comprising (i) at least one endolysin derived from a Staphylococcus aureus phage; and (ii) mannitol, the endolysin comprising a protein sequence having at least 80% sequence identity with an amino acid sequence selected from the group consisting of the reference amino acid sequences SEQ ID NO: 1 and SEQ ID NO: 2. It also relates to a composition comprising, in a physiologically acceptable medium, at least one anhydrous composition of the invention.It also covers the use of such a composition to prevent and / or treat a skin disorder related to Staphylococcus aureus colonization in an individual in need, and a non-therapeutic cosmetic process for the care of keratinous materials comprising at least one step of topical application of such a composition to said keratinous materials. Finally, it covers a process for stabilizing an endolysin derived from a Staphylococcus aureus phage. Figure for the abstract: None.
Owner:LOREAL SA

Cosmetic composition, particularly aqueous, comprising an endolysin and a pullulan

A cosmetic composition, particularly aqueous, comprising an endolysin and a pullulan. The present invention relates to a composition, particularly a cosmetic one, comprising, in a physiologically acceptable medium, at least one endolysin, in particular an endolysin derived from a Staphylococcus aureus phage, and at least one pullulan. It also relates to the use of such a composition to prevent and / or treat a skin disorder related to Staphylococcus aureus colonization in an individual in need, and in particular to prevent and / or treat acne and / or eczema in an individual in need, and a non-therapeutic cosmetic method for the care of keratinous materials, particularly skin, comprising at least one step of topical application of such a composition to said keratinous materials. Figure for abstract: None
Owner:LOREAL SA